Portage biotech announces participation in september 2021 investor conferences

Westport, conn., sept. 10, 2021 (globe newswire) -- portage biotech inc. (nasdaq: prtg) (“portage” or the “company”), a clinical-stage immuno-oncology company focused on the development of therapies and treatments targeting cancer treatment resistance, today announced that as part of its commitment to investor outreach, management will be participating in the following investor conferences in september 2021.
ATON Ratings Summary
ATON Quant Ranking